Influence of Cell Cycle on Responses of MCF-7 Cells to Benzo[a]pyrene

Overview

Journal BMC Genomics

Publisher Biomed Central

Specialty Genetics

Date 2011 Jul 1

PMID 21714911

Citations 20

Authors

Hamza Hamouchene

Volker M Arlt

Ian Giddings

David H Phillips

Affiliations

Soon will be listed here.

Abstract

Background: Benzo[a]pyrene (BaP) is a widespread environmental genotoxic carcinogen that damages DNA by forming adducts. This damage along with activation of the aryl hydrocarbon receptor (AHR) induces complex transcriptional responses in cells. To investigate whether human cells are more susceptible to BaP in a particular phase of the cell cycle, synchronised breast carcinoma MCF-7 cells were exposed to BaP. Cell cycle progression was analysed by flow cytometry, DNA adduct formation was assessed by 32P-postlabeling analysis, microarrays of 44K human genome-wide oligos and RT-PCR were used to detect gene expression (mRNA) changes and Western blotting was performed to determine the expression of some proteins, including cytochrome P450 (CYP) 1A1 and CYP1B1, which are involved in BaP metabolism.

Results: Following BaP exposure, cells evaded G1 arrest and accumulated in S-phase. Higher levels of DNA damage occurred in S- and G2/M- compared with G0/G1-enriched cultures. Genes that were found to have altered expression included those involved in xenobiotic metabolism, apoptosis, cell cycle regulation and DNA repair. Gene ontology and pathway analysis showed the involvement of various signalling pathways in response to BaP exposure, such as the Catenin/Wnt pathway in G1, the ERK pathway in G1 and S, the Nrf2 pathway in S and G2/M and the Akt pathway in G2/M. An important finding was that higher levels of DNA damage in S- and G2/M-enriched cultures correlated with higher levels of CYP1A1 and CYP1B1 mRNA and proteins. Moreover, exposure of synchronised MCF-7 cells to BaP-7,8-diol-9,10-epoxide (BPDE), the ultimate carcinogenic metabolite of BaP, did not result in significant changes in DNA adduct levels at different phases of the cell cycle.

Conclusions: This study characterised the complex gene response to BaP in MCF-7 cells and revealed a strong correlation between the varying efficiency of BaP metabolism and DNA damage in different phases of the cell cycle. Our results suggest that growth kinetics within a target-cell population may be important determinants of susceptibility and response to a genotoxic agent.

Citing Articles

Benzo[a]pyrene disrupts LH/hCG-dependent mouse Leydig cell steroidogenesis through receptor/Gαs protein targeting.

Lazzaretti C, Roy N, Paradiso E, Capponi C, Ferrari T, Reggianini F Sci Rep. 2024; 14(1):844.

PMID: 38191651 PMC: 10774265. DOI: 10.1038/s41598-024-51516-7.

Azadirachtin Attenuates Carcinogen Benzo(a) Pyrene-Induced DNA Damage, Cell Cycle Arrest, Apoptosis, Inflammatory, Metabolic, and Oxidative Stress in HepG2 Cells.

John A, Raza H Antioxidants (Basel). 2023; 12(11).

PMID: 38001854 PMC: 10669168. DOI: 10.3390/antiox12112001.

Metabolic Activation of Benzo[]pyrene by Human Tissue Organoid Cultures.

Caipa Garcia A, Kucab J, Al-Serori H, Beck R, Fischer F, Hufnagel M Int J Mol Sci. 2023; 24(1).

PMID: 36614051 PMC: 9820386. DOI: 10.3390/ijms24010606.

Gold nanoparticle uptake is enhanced by estradiol in MCF-7 breast cancer cells.

Lara-Cruz C, Jimenez-Salazar J, Arteaga M, Arredondo M, Ramon-Gallegos E, Batina N Int J Nanomedicine. 2019; 14:2705-2718.

PMID: 31118607 PMC: 6503330. DOI: 10.2147/IJN.S196683.

The impact of p53 function on the metabolic activation of the carcinogenic air pollutant 3-nitrobenzanthrone and its metabolites 3-aminobenzanthrone and N-hydroxy-3-aminobenzanthrone in human cells.

Wohak L, Baranski A, Krais A, Schmeiser H, Phillips D, Arlt V Mutagenesis. 2018; 33(4):311-321.

PMID: 30215795 PMC: 6180618. DOI: 10.1093/mutage/gey025.

References

Phillips D . Fifty years of benzo(a)pyrene. Nature. 1983; 303(5917):468-72. DOI: 10.1038/303468a0. View

Strelau J, Schmeer C, Peterziel H, Sackmann T, Herold-Mende C, Steiner H . Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines. Cancer Lett. 2008; 270(1):30-9. DOI: 10.1016/j.canlet.2008.04.042. View

Duriez C, Moyret-Lalle C, Falette N, El-Ghissassi F, Puisieux A . BTG2, its family and its tutor. Bull Cancer. 2004; 91(7-8):E242-53. View

Ikuta T, Kobayashi Y, Kawajiri K . Cell density regulates intracellular localization of aryl hydrocarbon receptor. J Biol Chem. 2004; 279(18):19209-16. DOI: 10.1074/jbc.M310492200. View

Santini R, Myrand S, Elferink C, Reiners Jr J . Regulation of Cyp1a1 induction by dioxin as a function of cell cycle phase. J Pharmacol Exp Ther. 2001; 299(2):718-28. View

Anwar A, Dehn D, Siegel D, Kepa J, Tang L, Pietenpol J . Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem. 2003; 278(12):10368-73. DOI: 10.1074/jbc.M211981200. View

Bartosiewicz M, Penn S, Buckpitt A . Applications of gene arrays in environmental toxicology: fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ Health Perspect. 2001; 109(1):71-4. PMC: 1242054. DOI: 10.1289/ehp.0110971. View

van Delft J, van Agen E, Van Breda S, Herwijnen M, Staal Y, Kleinjans J . Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis. 2004; 25(7):1265-76. DOI: 10.1093/carcin/bgh108. View

Ou Y, Chung P, Hsu F, Sun T, Chang W, Shieh S . The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J. 2007; 26(17):3968-80. PMC: 1994125. DOI: 10.1038/sj.emboj.7601825. View

10.

Puga A, Ma C, Marlowe J . The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol. 2008; 77(4):713-22. PMC: 2657192. DOI: 10.1016/j.bcp.2008.08.031. View

11.

Gu Y, Hogenesch J, Bradfield C . The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol. 2000; 40:519-61. DOI: 10.1146/annurev.pharmtox.40.1.519. View

12.

Yin X, Dewille J, Hai T . A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene. 2007; 27(15):2118-27. DOI: 10.1038/sj.onc.1210861. View

13.

Tsang W, Wang L, Chen Z, Sanchez I, Dynlacht B . SCAPER, a novel cyclin A-interacting protein that regulates cell cycle progression. J Cell Biol. 2007; 178(4):621-33. PMC: 2064469. DOI: 10.1083/jcb.200701166. View

14.

Wu M, Wu W, Chang G, Chen C, Hu S, Tsai W . Increased expression of cytochrome P4501B1 in peripheral leukocytes from lung cancer patients. Toxicol Lett. 2004; 150(2):211-9. DOI: 10.1016/j.toxlet.2004.01.006. View

15.

Mitchell K, Elferink C . Timing is everything: consequences of transient and sustained AhR activity. Biochem Pharmacol. 2008; 77(6):947-56. PMC: 2751579. DOI: 10.1016/j.bcp.2008.10.028. View

16.

Thiel G, Cibelli G . Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol. 2002; 193(3):287-92. DOI: 10.1002/jcp.10178. View

17.

Phillips D, Arlt V . The 32P-postlabeling assay for DNA adducts. Nat Protoc. 2007; 2(11):2772-81. DOI: 10.1038/nprot.2007.394. View

18.

Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Craig R . Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51(23 Pt 1):6304-11. View

19.

Grisendi S, Mecucci C, Falini B, Pandolfi P . Nucleophosmin and cancer. Nat Rev Cancer. 2006; 6(7):493-505. DOI: 10.1038/nrc1885. View

20.

Kastan M, Bartek J . Cell-cycle checkpoints and cancer. Nature. 2004; 432(7015):316-23. DOI: 10.1038/nature03097. View